Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials

Highlights • The paper reports for the first time patterns of progression in type 2 and 3 SMA. • Different trajectories can be identified in ambulant and non-ambulant patients. • Age appears to be an important factor in determining trajectories of progression.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuromuscular disorders : NMD 2016-02, Vol.26 (2), p.126-131
Hauptverfasser: Mercuri, Eugenio, Finkel, Richard, Montes, Jacqueline, Mazzone, Elena S, Sormani, Maria Pia, Main, Marion, Ramsey, Danielle, Mayhew, Anna, Glanzman, Allan M, Dunaway, Sally, Salazar, Rachel, Pasternak, Amy, Quigley, Janet, Pane, Marika, Pera, Maria Carmela, Scoto, Mariacristina, Messina, Sonia, Sframeli, Maria, Vita, Gian Luca, D'Amico, Adele, van den Hauwe, Marleen, Sivo, Serena, Goemans, Nathalie, Kaufmann, Petra, Darras, Basil T, Bertini, Enrico, Muntoni, Francesco, De Vivo, Darryl C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 131
container_issue 2
container_start_page 126
container_title Neuromuscular disorders : NMD
container_volume 26
creator Mercuri, Eugenio
Finkel, Richard
Montes, Jacqueline
Mazzone, Elena S
Sormani, Maria Pia
Main, Marion
Ramsey, Danielle
Mayhew, Anna
Glanzman, Allan M
Dunaway, Sally
Salazar, Rachel
Pasternak, Amy
Quigley, Janet
Pane, Marika
Pera, Maria Carmela
Scoto, Mariacristina
Messina, Sonia
Sframeli, Maria
Vita, Gian Luca
D'Amico, Adele
van den Hauwe, Marleen
Sivo, Serena
Goemans, Nathalie
Kaufmann, Petra
Darras, Basil T
Bertini, Enrico
Muntoni, Francesco
De Vivo, Darryl C
description Highlights • The paper reports for the first time patterns of progression in type 2 and 3 SMA. • Different trajectories can be identified in ambulant and non-ambulant patients. • Age appears to be an important factor in determining trajectories of progression.
doi_str_mv 10.1016/j.nmd.2015.10.006
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4762230</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0960896615300560</els_id><sourcerecordid>1764341097</sourcerecordid><originalsourceid>FETCH-LOGICAL-c609t-ddbd59a91603aab6b69dbee2ac982789c2205d284b661915b34ec2dba64dbc1d3</originalsourceid><addsrcrecordid>eNqNkk9v1DAQxS0EokvhA3BBPnLJ4j_JJAapUlVBW6kIpNKz5dizxUtiBztbab89jratgAPiNPL4vSd7fkPIa87WnHF4t12H0a0F4005rxmDJ2TFu1ZWQkL9lKyYAlZ1CuCIvMh5y4qwhfY5ORLQttAwuSI3X808YwqZxg11PqPJSKcUbxPm7GOgPtB5PyEV1ARHJb3-fPqeXo7T4K2ZiyDTTUzUDj6UxkDn5M2QX5Jnm1Lw1X09JjefPn47u6iuvpxfnp1eVRaYmivnetcoozgwaUwPPSjXIwpjVSfaTlkhWONEV_cAXPGmlzVa4XoDtestd_KYnBxyp10_orMY5mQGPSU_mrTX0Xj9503w3_VtvNN1C0JIVgLe3gek-HOHedajzxaHwQSMu6x5q8oQmwbgP6RQy5oz1RYpP0htijkn3Dy-iDO9kNNbXcjphdzSKuSK583vX3l0PKAqgg8HAZaB3nlMOluPwaLzCe2sXfT_jD_5y_2A7AfuMW_jLoVCSnOdhWb6elmdZXN4IxlrCp9fmOq-qg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1764341097</pqid></control><display><type>article</type><title>Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Mercuri, Eugenio ; Finkel, Richard ; Montes, Jacqueline ; Mazzone, Elena S ; Sormani, Maria Pia ; Main, Marion ; Ramsey, Danielle ; Mayhew, Anna ; Glanzman, Allan M ; Dunaway, Sally ; Salazar, Rachel ; Pasternak, Amy ; Quigley, Janet ; Pane, Marika ; Pera, Maria Carmela ; Scoto, Mariacristina ; Messina, Sonia ; Sframeli, Maria ; Vita, Gian Luca ; D'Amico, Adele ; van den Hauwe, Marleen ; Sivo, Serena ; Goemans, Nathalie ; Kaufmann, Petra ; Darras, Basil T ; Bertini, Enrico ; Muntoni, Francesco ; De Vivo, Darryl C</creator><creatorcontrib>Mercuri, Eugenio ; Finkel, Richard ; Montes, Jacqueline ; Mazzone, Elena S ; Sormani, Maria Pia ; Main, Marion ; Ramsey, Danielle ; Mayhew, Anna ; Glanzman, Allan M ; Dunaway, Sally ; Salazar, Rachel ; Pasternak, Amy ; Quigley, Janet ; Pane, Marika ; Pera, Maria Carmela ; Scoto, Mariacristina ; Messina, Sonia ; Sframeli, Maria ; Vita, Gian Luca ; D'Amico, Adele ; van den Hauwe, Marleen ; Sivo, Serena ; Goemans, Nathalie ; Kaufmann, Petra ; Darras, Basil T ; Bertini, Enrico ; Muntoni, Francesco ; De Vivo, Darryl C</creatorcontrib><description>Highlights • The paper reports for the first time patterns of progression in type 2 and 3 SMA. • Different trajectories can be identified in ambulant and non-ambulant patients. • Age appears to be an important factor in determining trajectories of progression.</description><identifier>ISSN: 0960-8966</identifier><identifier>EISSN: 1873-2364</identifier><identifier>DOI: 10.1016/j.nmd.2015.10.006</identifier><identifier>PMID: 26776503</identifier><language>eng</language><publisher>England: Elsevier B.V</publisher><subject>Adolescent ; Adult ; Child ; Child, Preschool ; Clinical Trials as Topic ; Disease Progression ; Female ; Hammersmith Functional Motor Scale ; Humans ; Male ; Middle Aged ; Mobility Limitation ; Neurology ; Outcome measures ; Retrospective Studies ; Spinal Muscular Atrophies of Childhood - physiopathology ; Spinal muscular atrophy ; Young Adult</subject><ispartof>Neuromuscular disorders : NMD, 2016-02, Vol.26 (2), p.126-131</ispartof><rights>The Authors</rights><rights>2015 The Authors</rights><rights>Copyright © 2015 The Authors. Published by Elsevier B.V. All rights reserved.</rights><rights>2015 The Authors 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c609t-ddbd59a91603aab6b69dbee2ac982789c2205d284b661915b34ec2dba64dbc1d3</citedby><cites>FETCH-LOGICAL-c609t-ddbd59a91603aab6b69dbee2ac982789c2205d284b661915b34ec2dba64dbc1d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.nmd.2015.10.006$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26776503$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mercuri, Eugenio</creatorcontrib><creatorcontrib>Finkel, Richard</creatorcontrib><creatorcontrib>Montes, Jacqueline</creatorcontrib><creatorcontrib>Mazzone, Elena S</creatorcontrib><creatorcontrib>Sormani, Maria Pia</creatorcontrib><creatorcontrib>Main, Marion</creatorcontrib><creatorcontrib>Ramsey, Danielle</creatorcontrib><creatorcontrib>Mayhew, Anna</creatorcontrib><creatorcontrib>Glanzman, Allan M</creatorcontrib><creatorcontrib>Dunaway, Sally</creatorcontrib><creatorcontrib>Salazar, Rachel</creatorcontrib><creatorcontrib>Pasternak, Amy</creatorcontrib><creatorcontrib>Quigley, Janet</creatorcontrib><creatorcontrib>Pane, Marika</creatorcontrib><creatorcontrib>Pera, Maria Carmela</creatorcontrib><creatorcontrib>Scoto, Mariacristina</creatorcontrib><creatorcontrib>Messina, Sonia</creatorcontrib><creatorcontrib>Sframeli, Maria</creatorcontrib><creatorcontrib>Vita, Gian Luca</creatorcontrib><creatorcontrib>D'Amico, Adele</creatorcontrib><creatorcontrib>van den Hauwe, Marleen</creatorcontrib><creatorcontrib>Sivo, Serena</creatorcontrib><creatorcontrib>Goemans, Nathalie</creatorcontrib><creatorcontrib>Kaufmann, Petra</creatorcontrib><creatorcontrib>Darras, Basil T</creatorcontrib><creatorcontrib>Bertini, Enrico</creatorcontrib><creatorcontrib>Muntoni, Francesco</creatorcontrib><creatorcontrib>De Vivo, Darryl C</creatorcontrib><title>Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials</title><title>Neuromuscular disorders : NMD</title><addtitle>Neuromuscul Disord</addtitle><description>Highlights • The paper reports for the first time patterns of progression in type 2 and 3 SMA. • Different trajectories can be identified in ambulant and non-ambulant patients. • Age appears to be an important factor in determining trajectories of progression.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Clinical Trials as Topic</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Hammersmith Functional Motor Scale</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mobility Limitation</subject><subject>Neurology</subject><subject>Outcome measures</subject><subject>Retrospective Studies</subject><subject>Spinal Muscular Atrophies of Childhood - physiopathology</subject><subject>Spinal muscular atrophy</subject><subject>Young Adult</subject><issn>0960-8966</issn><issn>1873-2364</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkk9v1DAQxS0EokvhA3BBPnLJ4j_JJAapUlVBW6kIpNKz5dizxUtiBztbab89jratgAPiNPL4vSd7fkPIa87WnHF4t12H0a0F4005rxmDJ2TFu1ZWQkL9lKyYAlZ1CuCIvMh5y4qwhfY5ORLQttAwuSI3X808YwqZxg11PqPJSKcUbxPm7GOgPtB5PyEV1ARHJb3-fPqeXo7T4K2ZiyDTTUzUDj6UxkDn5M2QX5Jnm1Lw1X09JjefPn47u6iuvpxfnp1eVRaYmivnetcoozgwaUwPPSjXIwpjVSfaTlkhWONEV_cAXPGmlzVa4XoDtestd_KYnBxyp10_orMY5mQGPSU_mrTX0Xj9503w3_VtvNN1C0JIVgLe3gek-HOHedajzxaHwQSMu6x5q8oQmwbgP6RQy5oz1RYpP0htijkn3Dy-iDO9kNNbXcjphdzSKuSK583vX3l0PKAqgg8HAZaB3nlMOluPwaLzCe2sXfT_jD_5y_2A7AfuMW_jLoVCSnOdhWb6elmdZXN4IxlrCp9fmOq-qg</recordid><startdate>20160201</startdate><enddate>20160201</enddate><creator>Mercuri, Eugenio</creator><creator>Finkel, Richard</creator><creator>Montes, Jacqueline</creator><creator>Mazzone, Elena S</creator><creator>Sormani, Maria Pia</creator><creator>Main, Marion</creator><creator>Ramsey, Danielle</creator><creator>Mayhew, Anna</creator><creator>Glanzman, Allan M</creator><creator>Dunaway, Sally</creator><creator>Salazar, Rachel</creator><creator>Pasternak, Amy</creator><creator>Quigley, Janet</creator><creator>Pane, Marika</creator><creator>Pera, Maria Carmela</creator><creator>Scoto, Mariacristina</creator><creator>Messina, Sonia</creator><creator>Sframeli, Maria</creator><creator>Vita, Gian Luca</creator><creator>D'Amico, Adele</creator><creator>van den Hauwe, Marleen</creator><creator>Sivo, Serena</creator><creator>Goemans, Nathalie</creator><creator>Kaufmann, Petra</creator><creator>Darras, Basil T</creator><creator>Bertini, Enrico</creator><creator>Muntoni, Francesco</creator><creator>De Vivo, Darryl C</creator><general>Elsevier B.V</general><general>Pergamon Press</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope><scope>5PM</scope></search><sort><creationdate>20160201</creationdate><title>Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials</title><author>Mercuri, Eugenio ; Finkel, Richard ; Montes, Jacqueline ; Mazzone, Elena S ; Sormani, Maria Pia ; Main, Marion ; Ramsey, Danielle ; Mayhew, Anna ; Glanzman, Allan M ; Dunaway, Sally ; Salazar, Rachel ; Pasternak, Amy ; Quigley, Janet ; Pane, Marika ; Pera, Maria Carmela ; Scoto, Mariacristina ; Messina, Sonia ; Sframeli, Maria ; Vita, Gian Luca ; D'Amico, Adele ; van den Hauwe, Marleen ; Sivo, Serena ; Goemans, Nathalie ; Kaufmann, Petra ; Darras, Basil T ; Bertini, Enrico ; Muntoni, Francesco ; De Vivo, Darryl C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c609t-ddbd59a91603aab6b69dbee2ac982789c2205d284b661915b34ec2dba64dbc1d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Clinical Trials as Topic</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Hammersmith Functional Motor Scale</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mobility Limitation</topic><topic>Neurology</topic><topic>Outcome measures</topic><topic>Retrospective Studies</topic><topic>Spinal Muscular Atrophies of Childhood - physiopathology</topic><topic>Spinal muscular atrophy</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mercuri, Eugenio</creatorcontrib><creatorcontrib>Finkel, Richard</creatorcontrib><creatorcontrib>Montes, Jacqueline</creatorcontrib><creatorcontrib>Mazzone, Elena S</creatorcontrib><creatorcontrib>Sormani, Maria Pia</creatorcontrib><creatorcontrib>Main, Marion</creatorcontrib><creatorcontrib>Ramsey, Danielle</creatorcontrib><creatorcontrib>Mayhew, Anna</creatorcontrib><creatorcontrib>Glanzman, Allan M</creatorcontrib><creatorcontrib>Dunaway, Sally</creatorcontrib><creatorcontrib>Salazar, Rachel</creatorcontrib><creatorcontrib>Pasternak, Amy</creatorcontrib><creatorcontrib>Quigley, Janet</creatorcontrib><creatorcontrib>Pane, Marika</creatorcontrib><creatorcontrib>Pera, Maria Carmela</creatorcontrib><creatorcontrib>Scoto, Mariacristina</creatorcontrib><creatorcontrib>Messina, Sonia</creatorcontrib><creatorcontrib>Sframeli, Maria</creatorcontrib><creatorcontrib>Vita, Gian Luca</creatorcontrib><creatorcontrib>D'Amico, Adele</creatorcontrib><creatorcontrib>van den Hauwe, Marleen</creatorcontrib><creatorcontrib>Sivo, Serena</creatorcontrib><creatorcontrib>Goemans, Nathalie</creatorcontrib><creatorcontrib>Kaufmann, Petra</creatorcontrib><creatorcontrib>Darras, Basil T</creatorcontrib><creatorcontrib>Bertini, Enrico</creatorcontrib><creatorcontrib>Muntoni, Francesco</creatorcontrib><creatorcontrib>De Vivo, Darryl C</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neuromuscular disorders : NMD</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mercuri, Eugenio</au><au>Finkel, Richard</au><au>Montes, Jacqueline</au><au>Mazzone, Elena S</au><au>Sormani, Maria Pia</au><au>Main, Marion</au><au>Ramsey, Danielle</au><au>Mayhew, Anna</au><au>Glanzman, Allan M</au><au>Dunaway, Sally</au><au>Salazar, Rachel</au><au>Pasternak, Amy</au><au>Quigley, Janet</au><au>Pane, Marika</au><au>Pera, Maria Carmela</au><au>Scoto, Mariacristina</au><au>Messina, Sonia</au><au>Sframeli, Maria</au><au>Vita, Gian Luca</au><au>D'Amico, Adele</au><au>van den Hauwe, Marleen</au><au>Sivo, Serena</au><au>Goemans, Nathalie</au><au>Kaufmann, Petra</au><au>Darras, Basil T</au><au>Bertini, Enrico</au><au>Muntoni, Francesco</au><au>De Vivo, Darryl C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials</atitle><jtitle>Neuromuscular disorders : NMD</jtitle><addtitle>Neuromuscul Disord</addtitle><date>2016-02-01</date><risdate>2016</risdate><volume>26</volume><issue>2</issue><spage>126</spage><epage>131</epage><pages>126-131</pages><issn>0960-8966</issn><eissn>1873-2364</eissn><abstract>Highlights • The paper reports for the first time patterns of progression in type 2 and 3 SMA. • Different trajectories can be identified in ambulant and non-ambulant patients. • Age appears to be an important factor in determining trajectories of progression.</abstract><cop>England</cop><pub>Elsevier B.V</pub><pmid>26776503</pmid><doi>10.1016/j.nmd.2015.10.006</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0960-8966
ispartof Neuromuscular disorders : NMD, 2016-02, Vol.26 (2), p.126-131
issn 0960-8966
1873-2364
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4762230
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Adolescent
Adult
Child
Child, Preschool
Clinical Trials as Topic
Disease Progression
Female
Hammersmith Functional Motor Scale
Humans
Male
Middle Aged
Mobility Limitation
Neurology
Outcome measures
Retrospective Studies
Spinal Muscular Atrophies of Childhood - physiopathology
Spinal muscular atrophy
Young Adult
title Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T04%3A39%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Patterns%20of%20disease%20progression%20in%20type%202%20and%203%20SMA:%20Implications%20for%20clinical%20trials&rft.jtitle=Neuromuscular%20disorders%20:%20NMD&rft.au=Mercuri,%20Eugenio&rft.date=2016-02-01&rft.volume=26&rft.issue=2&rft.spage=126&rft.epage=131&rft.pages=126-131&rft.issn=0960-8966&rft.eissn=1873-2364&rft_id=info:doi/10.1016/j.nmd.2015.10.006&rft_dat=%3Cproquest_pubme%3E1764341097%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1764341097&rft_id=info:pmid/26776503&rft_els_id=1_s2_0_S0960896615300560&rfr_iscdi=true